Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Achievement and NRAS[original query] |
---|
Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG). Blood 2013 Jan 121 (1): 170-7. Paschka Peter, Du Juan, Schlenk Richard F, Gaidzik Verena I, Bullinger Lars, Corbacioglu Andrea, Späth Daniela, Kayser Sabine, Schlegelberger Brigitte, Krauter Jürgen, Ganser Arnold, Köhne Claus-Henning, Held Gerhard, von Lilienfeld-Toal Marie, Kirchen Heinz, Rummel Mathias, Götze Katharina, Horst Heinz-August, Ringhoffer Mark, Lübbert Michael, Wattad Mohammed, Salih Helmut R, Kündgen Andrea, Döhner Hartmut, Döhner Konstan |
[Detection of activating mutations in RAS/RAF/MEK/ERK and JAK/STAT signaling pathways]. Terapevticheskii arkhiv 2020 12 92 (7): 31-42. Zarubina K I, Parovichnikova E N, Surin V L, Pshenichnikova O S, Gavrilina O A, Isinova G A, Troitskaia V V, Sokolov A N, Gal'tseva I V, Kapranov N M, Davydova I O, Obukhova T N, Sudarikov A B, Savchenko V |
Lack of Influence of Non-Overlapping Mutations in BRAF, NRAS, or NF1 on 12-Month Best Objective Response and Long-Term Survival after Checkpoint Inhibitor-Based Treatment for Metastatic Melanoma. Cancers 2023 7 15 (13): . Alyssa Panning, Wolfram Samlowski, Gabriel Allr |
- Page last reviewed:Feb 1, 2024
- Content source: